Vaginal Rejuvenation: Myths, Realities, & Medical Insights

madman · 2026-01-20T17:13:09-0600

Vaginal rejuvenation is often misunderstood, misrepresented, and overdue for honest conversations in medicine. In this crossover episode between BackTable Urology and BackTable OBGYN, Dr. Nirit Rosenblum, a urology and OBGYN professor at NYU Langone Medical Center, is joined by Dr. Karyn Eilber, Chair of the Cedars-Sinai Medical Group Department of Surgery, and Dr. Ariana Smith, Chief of Urology at Pennsylvania Hospital. Together, they bring a multidisciplinary lens to one of the most misunderstood areas of women’s health.

SYNPOSIS

The discussion revolves around the broad definition of vaginal rejuvenation, distinguishing between medical and cosmetic interventions. They address common misconceptions, the roles of different health professionals, and emphasize the importance of pelvic floor physical therapy and the appropriate use of systemic and vaginal estrogen therapy. The conversation also highlights critical gaps in research surrounding laser and radiofrequency interventions, underscoring the need for stronger evidence, clearer patient education, and continued advocacy around menopause care and sexual function.

TIMESTAMPS

00:00 - Introduction
02:07 - Defining Vaginal Rejuvenation
04:31 - Common Procedures and Misconceptions
10:00 - Insurance and Coverage of Procedures
12:00 - Laser and Radiofrequency Therapies
18:06 - Vaginal Estrogen and Lift of Black Box Warning
19:55 - The Role of Systemic Hormone Therapy
26:52 - Vaginal Rejuvenation Misconceptions
32:17 - Pelvic Floor Physical Therapy and Timing of Procedures
34:20 - Regional Variations in Therapeutic Availability
38:36 - Gender Inequity in Healthcare
40:12 - Final Thoughts

madman · 2026-01-20T17:21:12-0600

Thread 'ARs can play an important role in the vulvovaginal area'

Oct 30, 2020

Expression of androgen receptors in the structures of vulvovaginal tissue
Santiago Palacios, MD

Abstract

Importance and Objective: Little is known about the role of androgens in the female genital tract, specifically in the vulvovaginal area. The abundance of androgen receptors in this area could help us to explain their role. The main objective of the present article is to review current data on androgen receptors in the different structures of vulvovaginal tissues.

Methods: A review of the literature using data from PubMed was carried out...

Thread 'Testosterone and Vaginal Function'

May 21, 2020

Testosterone and Vaginal Function
Elisa Maseroli , Linda Vignozzi

Abstract

Introduction: Androgens have been shown to exert beneficial effects on vaginal physiology, at least partially independent of their aromatization to estrogens. Androgen deficiency in the vagina and in the other genitourinary tissues contributes to the development of vulvovaginal atrophy and genitourinary syndrome of menopause, resulting in impaired arousal and lubrication, and dyspareunia.

Objectives: To summarize the role...

Thread 'Androgen production within the human vagina'

Nov 29, 2020

Insight on the intracrinology of menopause: androgen production within the human vagina
Ilaria Cellai, Vincenza Di Stasi, Paolo Comeglio, Elisa Maseroli, Tommaso Todisco, Chiara Corno, Sandra Filippi, Sarah Cipriani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Irene Scavello, Giulia Rastrelli, Gabriele Acciai, Fabio Villanelli, Giovanna Danza, Erica Sarchielli, Giulia Guarnieri, Annamaria Morelli, Mario Maggi, Linda Vignozzi

Abstract

In this study, we investigated steroidogenic gene mRNA expression in human vaginas and verified the...

Thread 'Androgens' role in the vagina as a source and target'

Jun 17, 2023

Estrogens are traditionally believed to be the main hormones for vaginal health, but research shows vagina is also affected by androgens. The lack of approved testosterone treatments for vaginal symptoms led to the use of prasterone, which provides local DHEA to vaginal tissues, introducing a new androgenic element to therapy.

Thread 'THE EFFECT OF VAGINAL TESTOSTERONE ON SEXUAL FUNCTION AND VAGINAL HEALTH'

Mar 25, 2023

PD11-08 THE EFFECT OF VAGINAL TESTOSTERONE ON SEXUAL FUNCTION AND VAGINAL HEALTH: INTERIM ANALYSIS FOR PIVOT (PREVENTION OF RECURRENT URINARY TRACT INFECTION USING VAGINAL TESTOSTERONE) (2023)
Mariela Martinez*, Arshia Sandozi, Jeffrey Lee, Liliya Vafina, Claire Yin, Brooklyn, NY; Cassandra Pond, Robert Adelson, Annette Lee, Manhasset, NY; Allison Polland, Brooklyn, NY

INTRODUCTION AND OBJECTIVE

During menopause, declining estrogen levels can lead to vaginal atrophy and changes in vaginal flora. Vaginal estrogen treats atrophy thereby restoring flora, which...

Thread 'VAGINAL ESTROGEN: HOW AND WHY TO USE THEM TO KEEP THINGS NORMAL DOWN THERE!'

May 21, 2022

Vaginal estrogen products: Use them to keep things normal down there// Vaginal estrogen is a safe and effective way to treat the genitourinary system after menopause. This video discussed the safety of vaginal estrogen and the many different vaginal estrogen products that are commercially available for vaginal atrophy. Vaginal estrogen is also good for painful intercourse, recurrent urinary tract infections, and dryness with even sitting or standing. Learn all about the vaginal estrogen products that I often recommend.

Thread 'Current and emerging estrogen receptor agonists for vaginal atrophy'

Jan 25, 2025

ABSTRACT

Introduction

Vulvovaginal atrophy (VVA) predominantly affects postmenopausal women due to hormonal decline but can also occur in premenopausal women with conditions such as primary ovarian insufficiency or exposure to anti-estrogen medications. Contributing factors include smoking and certain medical treatments. Symptoms like dyspareunia and loss of sexual function affect many women but are underreported due to stigma and lack of awareness. Current treatments range from over-the-counter lubricants to hormonal therapies like estrogen receptor agonists...